Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett’s Esophagus is a research paper published in Diagnostics (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R44DK136424
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01CA287294
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK118250
NIH HHS
Grant: 1R01DK118250-22A5
NIH HHS
Grant: 1R01CA287294-23A1
NIH HHS
Grant: 1R44DK136424-23A1
National Institutes of Health
Grant: 5R44DK136424-02
Validation and Early Commercialization of the ENVISAGE Assay, a Prognostic Test for Barrett's Esophagus
National Institutes of Health
Grant: 9R01CA287294-06
Academic-Industrial Partnership for Barrett's Esophagus Detection and Risk Assessment
National Institutes of Health
Grant: 5R01DK118250-03
Academic-Industrial Partnership for Non-invasive Barrett's Esophagus Detection
FWCI
1.75
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords